Refoxy Pharma
Aignostics
Shengbao Bio
HepaRegeniX
Asgard Therapeutics
5 investments found
| Date | Investor | Investor* | Target | Round | Group | Amount (USD) | Country |
|---|---|---|---|---|---|---|---|
| 2024-12-04 | Boehringer Ingelheim | Boehringer Ingelheim Venture Fund |
Refoxy Pharma
|
Seed Round | 2 Seed | — | |
| 2024-10-29 | Boehringer Ingelheim | Boehringer Ingelheim Venture Fund |
Aignostics
|
Series B | 3 Early Growth | — | DE |
| 2024-07-26 | Boehringer Ingelheim | Boehringer Ingelheim Venture Fund |
Shengbao Bio
|
Series A | 3 Early Growth | — | |
| 2024-07-10 | Boehringer Ingelheim | Boehringer Ingelheim Venture Fund |
HepaRegeniX
|
Series C | 4 Growth | — | |
| 2024-03-14 | Boehringer Ingelheim | Boehringer Ingelheim Venture Fund |
Asgard Therapeutics
|
Series A | 3 Early Growth | — |